Asja Guzman

Asja Guzman

Auto-generated profile, based on publicly available information

Asja Guzman

Department of Biological Sciences, Columbia University, New York, New York

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2020 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
AGAsja Guzman
Asja Guzman
RARachel C. Avard
Rachel C. Avard
ADAlexander J. Devanny
Alexander J. Devanny
OKOh Sang Kweon
Oh Sang Kweon
LKLaura J. Kaufman
Laura J. Kaufman
The study of cancer cell invasion in 3D environments in vitro has revealed a variety of invasive modes, including amoeboid migration, characterized by primarily round cells that invade in a protease- and adhesion-independent manner. Here, we delineate a contractility-dependent migratory mode of primarily round breast cancer cells that is associated with extensive integrin-mediated extracellular matrix (ECM) reorganization that occurs at membrane blebs, with bleb necks sites of integrin clustering and integrin-dependent ECM alignment. We show that the spatiotemporal distribution of blebs and their utilization for ECM reorganization is mediated by functional β1 integrin receptors and other components of focal adhesions. Taken together, the work presented here characterizes a migratory mode of primarily round cancer cells in complex 3D environments and reveals a fundamentally new function for membrane blebs in cancer cell invasion.

17 April 2023 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
Joshua ChoeJoshua Choe
Joshua Choe
TKTatsuya Kawase
Tatsuya Kawase
AXAn Xu
An Xu
AGAsja Guzman
Asja Guzman
AOAleksandar Obradovic
Aleksandar Obradovic
CPCarol Prives
Carol Prives
Cancer-relevant mutations in the oligomerization domain (OD) of the p53 tumor suppressor protein, unlike those in the DNA binding domain, have not been well elucidated. Here, we characterized the germline OD mutant p53(A347D), which occurs in cancer-prone Li–Fraumeni syndrome (LFS) patients. Unlike wild-type p53, mutant p53(A347D) cannot form tetramers and exists as a hyperstable dimeric protein. Further, p53(A347D) cannot bind or transactivate the majority of canonical p53 target genes. Isogenic cell lines harboring either p53(A347D) or no p53 yield comparable tumorigenic properties, yet p53(A347D) displays remarkable neomorphic activities. Cells bearing p53(A347D) possess a distinct transcriptional profile and undergo metabolic reprogramming. Further, p53(A347D) induces striking mitochondrial network aberration and associates with mitochondria to drive apoptotic cell death upon topoisomerase II inhibition in the absence of transcription. Thus, dimer-forming p53 demonstrates both loss-of-function (LOF) and gain-of-function (GOF) properties compared with the wild-type form of the protein. Significance: A mutant p53 (A347D), which can only form dimers, is associated with increased cancer susceptibility in LFS individuals. We found that this mutant wields a double-edged sword, driving tumorigenesis through LOF while gaining enhanced apoptogenic activity as a new GOF, thereby yielding a potential vulnerability to select therapeutic approaches. See related commentary by Stieg et al., p. 1046. See related article by Gencel-Augusto et al., p. 1230. This article is highlighted in the In This Issue feature, p. 1027

4 May 2023
Verified
Other
Open access
PDF file
Joshua ChoeJoshua Choe
Joshua Choe
TKTatsuya Kawase
Tatsuya Kawase
AXAn Xu
An Xu
AGAsja Guzman
Asja Guzman
AOAleksandar Obradovic
Aleksandar Obradovic
CPCarol Prives
Carol Prives
Summary of GOF vs. LOF activities of p53(A347D) in U2OS cells

4 May 2023
Verified
Other
Open access
Joshua ChoeJoshua Choe
Joshua Choe
TKTatsuya Kawase
Tatsuya Kawase
AXAn Xu
An Xu
AGAsja Guzman
Asja Guzman
AOAleksandar Obradovic
Aleksandar Obradovic
CPCarol Prives
Carol Prives
Differentially expressed genes in U2OS cells varying in p53 allelic status combined from two independent RNA library preparations

17 April 2023
Verified
Other
Open access
PDF file
Joshua ChoeJoshua Choe
Joshua Choe
TKTatsuya Kawase
Tatsuya Kawase
AXAn Xu
An Xu
AGAsja Guzman
Asja Guzman
AOAleksandar Obradovic
Aleksandar Obradovic
CPCarol Prives
Carol Prives
Characteristics of LFS patients' fibroblasts and derivatives

4 May 2023
Verified
Other
Open access
Joshua ChoeJoshua Choe
Joshua Choe
TKTatsuya Kawase
Tatsuya Kawase
AXAn Xu
An Xu
AGAsja Guzman
Asja Guzman
AOAleksandar Obradovic
Aleksandar Obradovic
CPCarol Prives
Carol Prives
P53 ChIPseq peaks from osteoblasts derived from normal and LFS individuals